# Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine

> **NCT01276977** · NA · COMPLETED · sponsor: **California Medical Clinic for Headache** · enrollment: 80 (actual)

## Conditions studied

- Acute Migraine
- Migraine Headache
- Headache Disorders

## Interventions

- **DRUG:** Zolmitriptan 5 mg Nasal Spray
- **DRUG:** Eletriptan 40 mg tablet

## Key facts

- **NCT ID:** NCT01276977
- **Lead sponsor:** California Medical Clinic for Headache
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276977, "Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01276977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*